• Je něco špatně v tomto záznamu ?

Lippencreme mit 0,5 % Propolis-Spezialextrakt GH 2002 versus 5 % Aciclovir bei Herpes labialis (Bläschenstadium) : Randomisierte, kontrollierte Doppelblindstudie [Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage) : Randomized, controlled double-blind study]

J. Jautová, H. Zelenková, K. Drotarová, A. Nejdková, B. Grünwaldová, M. Hladiková,

. 2019 ; 169 (7-8) : 193-201. [pub] 20181107

Jazyk angličtina Země Rakousko

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028105

A lip cream with special propolis extract GH 2002 at a concentration of 0.5% (199 patients) was tested against aciclovir 5% (198 patients) in the treatment of episodes of herpes labialis under double-blind conditions. Upon inclusion, all patients were in the vesicular phase. Application was five times daily of approximately 0.2 g of cream to the entire upper and lower lip. The primary parameter was the difference in time between groups to complete encrustation or epithelization of the lesions. Secondary endpoints were the course of typical herpes symptoms (pain, burning and itching, tension and swelling), the global assessment of efficacy and the safety of application. The predefined clinical situation was reached after a (median) 3 days with propolis and 4 days with aciclovir (p < 0.0001). Significant differences in favor of propolis were also found for all secondary parameters. No allergic reactions, local irritations or other adverse events occurred.

Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage) : Randomized, controlled double-blind study

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028105
003      
CZ-PrNML
005      
20190819083833.0
007      
ta
008      
190813s2019 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10354-018-0667-6 $2 doi
035    __
$a (PubMed)30406509
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Jautová, Jagienka $u Department of Dermatology, Medical University of Kosice, Trieda SNP 1, 04011, Kosice, Slovakia. jakienka.jautova@post.sk.
245    10
$a Lippencreme mit 0,5 % Propolis-Spezialextrakt GH 2002 versus 5 % Aciclovir bei Herpes labialis (Bläschenstadium) : Randomisierte, kontrollierte Doppelblindstudie / $c J. Jautová, H. Zelenková, K. Drotarová, A. Nejdková, B. Grünwaldová, M. Hladiková,
246    31
$a Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage) : Randomized, controlled double-blind study.
520    9_
$a A lip cream with special propolis extract GH 2002 at a concentration of 0.5% (199 patients) was tested against aciclovir 5% (198 patients) in the treatment of episodes of herpes labialis under double-blind conditions. Upon inclusion, all patients were in the vesicular phase. Application was five times daily of approximately 0.2 g of cream to the entire upper and lower lip. The primary parameter was the difference in time between groups to complete encrustation or epithelization of the lesions. Secondary endpoints were the course of typical herpes symptoms (pain, burning and itching, tension and swelling), the global assessment of efficacy and the safety of application. The predefined clinical situation was reached after a (median) 3 days with propolis and 4 days with aciclovir (p < 0.0001). Significant differences in favor of propolis were also found for all secondary parameters. No allergic reactions, local irritations or other adverse events occurred.
650    _2
$a acyklovir $x terapeutické užití $7 D000212
650    _2
$a dospělí $7 D000328
650    12
$a antivirové látky $x terapeutické užití $7 D000998
650    _2
$a apiterapie $x metody $7 D056705
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a ženské pohlaví $7 D005260
650    12
$a herpes labialis $x farmakoterapie $7 D006560
650    _2
$a lidé $7 D006801
650    _2
$a ret $7 D008046
650    _2
$a mužské pohlaví $7 D008297
650    12
$a propolis $x terapeutické užití $7 D011429
650    _2
$a recidiva $7 D012008
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Zelenková, Hana $u Dermatological Clinic DOST, Dr. Pribulu 2, 08901, Svidnik, Slovakia.
700    1_
$a Drotarová, Katarína $u Dermatology Department, First Private Hospital, Lucna 57, 04015, Kosice, Slovakia.
700    1_
$a Nejdková, Alena $u Policlinica II Dermatology Ambulance, C. Spanyola 43, 01001, Zilina, Slovakia.
700    1_
$a Grünwaldová, Božena $u Dermatology Ambulance, Bernolakova 2476, 95501, Topolcany, Slovakia.
700    1_
$a Hladiková, Marie $u Department of Medical Informatics, Second Facultyof Medicine, Charles University of Prague, V Úvalu 84, 15006, Prague, Czech Republic.
773    0_
$w MED00010763 $t Wiener medizinische Wochenschrift (1946) $x 1563-258X $g Roč. 169, č. 7-8 (2019), s. 193-201
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30406509 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190819084107 $b ABA008
999    __
$a ok $b bmc $g 1433254 $s 1066565
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 169 $c 7-8 $d 193-201 $e 20181107 $i 1563-258X $m Wiener medizinische Wochenschrift (1946) $n Wien Med Wochenschr $x MED00010763
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace